SecBot SecBot
SECBOTREPLAY Home › Report › ATRA

ATRA · Brian N

Atara Biotherapeutics, Inc. · 3 filed Jun 15, 2026 at 18:48 ET

At the news

NEUTRALIMPACT 2/10

3 filed Jun 15, 2026 at 18:48 ET

Brian N. Cherry filed a Form 3 initial statement of beneficial ownership, reporting 38,320 shares of Atara Biotherapeutics common stock. This is a routine insider filing required upon becoming a Section 16 reporting person and conveys no material new information about the company's operations or financial condition.

  • Brian N. Cherry filed Form 3 as a new Section 16 reporting person of Atara Biotherapeutics, Inc.
  • Cherry reported beneficial ownership of 38,320 shares of common stock.
  • The filing includes a power of attorney authorizing Yanina Grant-Huerta and John Chao to execute Section 16 filings on his behalf.
  • The filing date is June 15, 2026, with a period of report of June 11, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access